The present application describes glycinamidic compounds and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
[EN] GLYCINAMIDES AS FACTOR XA INHIBITORS<br/>[FR] GLYCINAMIDES EN TANT QU'INHIBITEURS DU FACTEUR XA
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2003048158A1
公开(公告)日:2003-06-12
The present application describes glycinamidic compounds and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.